Alterity Therapeutics Raises AU$40 Million via Placement

MT Newswires Live

Feb 11, 2025

Alterity Therapeutics (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.

The first tranche of the placement is to raise about AU$12.8 million by issuing 1.2 billion shares and the second tranche is expected to raise about AU$27.2 million by issuing 2.5 billion shares.

Participants will also receive one free attached option per three shares subscribed exercisable at AU$0.028 expiring Feb. 26, 2027.

The proceeds will be used to fund ongoing clinical development programs for its Parkinson's disease drug candidate and general working capital, added the filing.

MST Financial Services was the lead manager for the placement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2510826250"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510826250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2510826250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-11 13:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510826250","market":"fut","top_or_hot":-1,"title":"Alterity Therapeutics Raises AU$40 Million via Placement","media":"MT Newswires Live","content":"<html><body><p> Alterity <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.</p><p>The first tranche of the placement is to raise about AU$12.8 million by issuing 1.2 billion shares and the second tranche is expected to raise about AU$27.2 million by issuing 2.5 billion shares.</p><p>Participants will also receive one free attached option per three shares subscribed exercisable at AU$0.028 expiring Feb. 26, 2027.</p><p>The proceeds will be used to fund ongoing clinical development programs for its Parkinson's disease drug candidate and general working capital, added the filing.</p><p>MST Financial Services was the lead manager for the placement.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Raises AU$40 Million via Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Raises AU$40 Million via Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-11 13:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Alterity <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.</p><p>The first tranche of the placement is to raise about AU$12.8 million by issuing 1.2 billion shares and the second tranche is expected to raise about AU$27.2 million by issuing 2.5 billion shares.</p><p>Participants will also receive one free attached option per three shares subscribed exercisable at AU$0.028 expiring Feb. 26, 2027.</p><p>The proceeds will be used to fund ongoing clinical development programs for its Parkinson's disease drug candidate and general working capital, added the filing.</p><p>MST Financial Services was the lead manager for the placement.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATH.AU","symbol_name":"ALTERITY THERAPEUTICS LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2510826250","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510826250","pubTimestamp":1739250305,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Alterity Therapeutics (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.The first tranche of the placement is to ra","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATH.AU":"ALTERITY THERAPEUTICS LTD","LENZ":"Therapeutics","BK4139":"生物科技","BK7067":"生物科技"},"translate_title":"Alterity Therapeutics通过配售筹集4000万澳元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATH.AU":0.9,"LENZ":1},"content_text":"Alterity Therapeutics (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.The first tranche of the placement is to raise about AU$12.8 million by issuing 1.2 billion shares and the second tranche is expected to raise about AU$27.2 million by issuing 2.5 billion shares.Participants will also receive one free attached option per three shares subscribed exercisable at AU$0.028 expiring Feb. 26, 2027.The proceeds will be used to fund ongoing clinical development programs for its Parkinson's disease drug candidate and general working capital, added the filing.MST Financial Services was the lead manager for the placement.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}